Risk Profile Improvements
- Going Concern (unchanged) — Company continues to disclose substantial doubt about ability to continue as going concern due to insufficient cash for next 12 months.
- Material Weakness (unchanged) — Internal control material weakness persists due to inadequate segregation of duties from limited resources.
Tenon Medical revenue doubles on new product, but cash burn persists with going concern
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TNONW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 25, 2026 9:40 AM